• Optimized hGBA1-mRNA Restores Lysosomal Function in Gaucher

  2026-06-01

  This study demonstrates that engineering human GBA1 mRNA markedly enhances glucocerebrosidase expression, localization, and function in both cellular and animal Gaucher disease models. The findings underscore mRNA-LNP therapy as a promising platform beyond current enzyme replacement approaches, with immediate applications for lysosomal storage disorder research and drug development.

• HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP

  2026-06-01

  This study uncovers how Epstein-Barr virus (EBV) drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) via epigenetic repression of CEBPA by LMP1 and HDAC recruitment. Targeting this pathway with HDAC inhibitors restores differentiation, suggesting a promising epigenetic strategy for overcoming therapy resistance in solid tumors.

• Direct Mouse Genotyping Kit: Rapid PCR from Mouse Tissue Lys

  2026-05-31

  The Direct Mouse Genotyping Kit enables direct PCR amplification from mouse tissue samples, eliminating the need for traditional DNA purification. This streamlines genotyping workflows in biomedical research, especially for routine or high-throughput applications. It is not recommended for protocols demanding ultra-pure DNA or downstream enzymatic steps beyond PCR.

• Sodium Phosphate Dibasic in Molecular Biology & Toxicity Ass

  2026-05-30

  Sodium phosphate dibasic (Na2HPO4) is a high-purity, water-soluble buffer essential for molecular biology and aquatic toxicity workflows. Its robust pH stabilization underpins reproducibility in enzyme and protein assays, while supporting advanced ecotoxicological studies like those assessing antibiotic impacts on aquatic life.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Next-Ge

  2026-05-29

  Explore the advanced mechanisms and applications of 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) for efficient nucleic acid delivery. This in-depth analysis reveals how DOTAP drives innovation in functional genomics and gene expression research.

• MRSA: Mechanisms, Epidemiology, and Insights from Turner et

  2026-05-29

  Turner et al. provide a comprehensive synthesis of methicillin-resistant Staphylococcus aureus (MRSA) research, elucidating the molecular basis of resistance, the serial emergence of epidemic strains, and key clinical challenges. Their review integrates molecular, epidemiological, and translational perspectives, highlighting persistent gaps in treatment and surveillance.

• TRIM66 as an Epigenetic Repressor in Monogenic Olfactory Exp

  2026-05-28

  This study identifies TRIM66 as a critical epigenetic repressor that enforces the singular expression of olfactory receptor genes in neurons. By delineating its mechanism, the work bridges a major knowledge gap in understanding how monogenic olfactory receptor selection is established and maintained, with implications for sensory biology and epigenetic research.

• Nintedanib (BIBF 1120): Optimized Workflows for Cancer & Fib

  2026-05-28

  Nintedanib (BIBF 1120) empowers researchers to dissect angiogenesis and fibrosis with nanomolar precision. This guide translates recent reference breakthroughs and real-world protocols into actionable steps for maximizing reproducibility and troubleshooting in advanced cancer models.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Mechanistic Ev

  2026-05-27

  The HyperScribe SP6 High Yield RNA Synthesis Kit enables rapid, high-yield in vitro transcription for research applications requiring precise, modified RNA. Robust evidence supports its ≥50 μg RNA yield per 20 μL reaction and high specificity for SP6-driven transcripts. This article critically reviews the kit’s biochemical rationale, performance, and experimental boundaries for RNA vaccine research and advanced probe synthesis.

• cgSHAPE-seq Maps SARS-CoV-2 RNA Degrader Binding at Nucleoti

  2026-05-27

  The reference study introduces cgSHAPE-seq, a chemical-guided sequencing technique that pinpoints the binding site of small-molecule RNA degraders on the highly conserved SL5 structure of the SARS-CoV-2 5' UTR. This approach enables rational design and optimization of RNA-targeting antivirals, with direct implications for targeting structured viral RNA elements.

• Sunitinib in Translational Oncology: Mechanism, Evidence, Ou

  2026-05-26

  This thought-leadership article explores Sunitinib’s role as a multi-targeted receptor tyrosine kinase inhibitor in translational cancer research, highlighting mechanistic insights, validated protocols, and evidence-based guidance for researchers. Drawing on recent discoveries—such as ATRX-deficient glioma sensitivity to RTK inhibition—the article discusses experimental rigor, competitive landscape, and future directions while contextualizing APExBIO’s Sunitinib as a benchmark tool. The discussion bridges advanced RTK pathway modulation with strategic considerations for translational model design, optimizing reproducibility and impact.

• Vitamin D Receptor Drives Ferroptosis and Salivary Hypofunct

  2026-05-26

  This study uncovers that vitamin D receptor (VDR) upregulation promotes ferroptosis-mediated salivary hyposecretion in female Sod1 knockout mice. The findings reveal a sex-specific mechanism linking oxidative stress, VDR signaling, and ferroptotic cell death in salivary glands, suggesting new research avenues for xerostomia and glandular dysfunction.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-05-25

  The Superoxide Dismutase (SOD) Activity Assay Kit provides a rapid, quantitative approach for measuring SOD enzyme activity in biological fluids and cell extracts, supporting oxidative stress assay workflows. It is not intended for diagnostic or clinical use, nor for direct mechanistic pathway elucidation. Researchers should apply this kit for validated colorimetric detection of antioxidative enzyme activity within controlled laboratory settings.

• Sunitinib: Multi-Targeted RTK Inhibitor Workflows in Oncolog

  2026-05-25

  Sunitinib stands apart as a multi-targeted receptor tyrosine kinase inhibitor, empowering translational oncology research with validated workflows for dissecting angiogenesis, apoptosis, and cell cycle arrest. This guide provides stepwise protocol enhancements, troubleshooting insights, and highlights innovative combinatorial strategies that overcome resistance in renal cell carcinoma.

• Sunitinib: Multi-Targeted RTK Inhibitor for Advanced Cancer

  2026-05-24

  Sunitinib stands out as a multi-targeted receptor tyrosine kinase inhibitor, enabling high-fidelity cancer research from cell-based assays to advanced combinatorial strategies. Recent evidence highlights its synergistic potential in overcoming resistance, especially in renal cell carcinoma models, empowering scientists with robust, reproducible experimental tools.

16356 records 1/1091 page Next 12345 下5页 Last page